Chemed Corporation (CHE) Tops Q2 EPS by 8c

Chemed Corporation (NYSE: CHE) reported Q2 EPS of $1.80, $0.08 better than the analyst estimate of $1.72. Revenue for the quarter came in at $290 million versus the consensus estimate of $394.66 million.

GUIDANCE:

Chemed Corporation sees FY2016 EPS of $7.15-$7.30, versus the consensus of $7.18. Excluding rebasing, 2016 guidance for adjusted earnings per diluted share would be in the range of $7.97 to $8.12.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.

You May Also Be Interested In

• Novartis (NVS) Tops Q1 EPS by 13c, raises guidance
• JPMorgan is worried about further S&P 500 sell-off potential
• Novartis hikes full-year guidance as Q1 results exceed estimates, shares pop